Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb;48(2):129-142.
doi: 10.1007/s40264-024-01485-7. Epub 2024 Sep 17.

Drug-Induced Hypouricemia

Chaker Ben Salem  1 , Myriam Agrebi  2 , Dhouha Sahnoun  2 , Neila Fathallah  2 , Houssem Hmouda  3
Affiliations
Review

Drug-Induced Hypouricemia

Chaker Ben Salem et al. Drug Saf. 2025 Feb.

Abstract

Hypouricemia is defined as a serum uric acid concentration of ≤ 2.0 mg/dL or 119 μmol/L. Hypouricemia may occur secondarily to a number of underlying conditions, including severe hepatocellular disease, neoplasia, defective renal tubular reabsorption of uric acid, inherited metabolic defect in purine metabolism, and drugs. Medications are an important cause of hypouricemia. They can cause hypouricemia by a variety of mechanisms. Drug-induced hypouricemia mostly occurs as overtreatment of hyperuricemia by urate-lowering therapies including xanthine oxidase inhibitors, uricosuric agents and uricases. Drugs not used in the treatment of gout may also lead to a decrease of uric acid levels. In this literature review, medications leading to hypouricemia are summarized with regard to their mechanism of action and clinical significance.

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: No funding. Conflict of interest: Authors have no conflicts of interest that are directly relevant to the content of this article. Ethics approval: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable. Availability of data and material: Upon reasonable request, data will be shared with qualified scientifc and medical researchers. All requests should be submitted in writing to the corresponding author. Code availability: Not applicable. Author contributions: CBS and MA performed the literature review and wrote the first draft of the manuscript. All authors made significant contribution to the writing, development, and editing of this manuscript. All authors read and approved the final version.

References

    1. Praetorius E, Kirk JE. Hypouricemia: with evidence for tubular elimination of uric acid. J Lab Clin Med. 1950;35:865–8. - PubMed
    1. Son CN, Kim JM, Kim SH, Cho SK, Choi CB, Sung YK, et al. Prevalence and possible causes of hypouricemia at a tertiary care hospital. Korean J Intern Med. 2016;31:971–6. - PubMed - PMC
    1. Ogino K, Hisatome I, Saitoh M, Miyamoto J, Ishiko R, Hasegawa J, et al. Clinical significance of hypouricemia in hospitalized patients. J Med. 1991;22:76–82. - PubMed
    1. Zhou Z, Ma L, Zhou J, Song Z, Zhang J, Wang K, et al. Renal hypouricemia caused by novel compound heterozygous mutations in the SLC22A12 gene: a case report with literature review. BMC Med Genet. 2018;19:142. - PubMed - PMC
    1. Iwai N, Mino Y, Hosoyamada M, Tago N, Kokubo Y, Endou H. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int. 2004;66:935–44. - PubMed

MeSH terms

LinkOut - more resources